Mammogram vs Ultrasound: Choosing Breast Imaging in India

• A mammogram uses low-dose X-rays and is the gold-standard test for screening average-risk women, usually from age 40 to 45 in India.
• An ultrasound uses sound waves and no radiation. It is the first choice for a lump in younger women, and for pregnant or breastfeeding women.
• Many Indian women have dense breasts, where mammograms miss more cancers, so a supplemental ultrasound is often added.
• The two tests are complementary, not competing; for a palpable lump in a woman 30 or older, both are usually done.
• Results are reported as a BIRADS score from 0 to 6. A score of 4 or 5 means a biopsy is recommended, but most biopsies turn out benign.
• Indian breast cancer tends to appear younger and at a more advanced stage, which is exactly why timely imaging and prompt evaluation of any change matter.

Both tests look inside the breast, but they answer different questions.

A mammogram is an X-ray of the breast. It is the only test proven to reduce deaths from breast cancer when used for routine screening, because it can pick up very early cancers, including tiny calcium specks (microcalcifications) that no other test or examination can detect. Its main weakness is dense breast tissue, where cancers can hide.

An ultrasound uses sound waves and a hand-held probe to create a live image. It uses no radiation and is excellent at answering the question "is this lump solid or just a fluid-filled cyst?" It is the go-to test for a lump in a young woman, for pregnant and breastfeeding women, and for guiding a biopsy needle.

The two are not rivals. For screening you usually start with a mammogram; for a symptom or an unclear mammogram finding you often add an ultrasound. Your doctor or radiologist chooses based on your age, your symptom, and your breast density, not on which test is "better" overall.

Mammography uses low-dose X-rays. The breast is gently compressed between two plates to spread the tissue out, which gives a clearer picture and lowers the radiation needed. Standard 2D mammography produces flat images; digital breast tomosynthesis (DBT, or 3D mammography) builds thin slices that reduce overlap of tissue and improve detection, especially in denser breasts.

On a mammogram, cancers can show up as a mass, an area of distorted architecture, an asymmetry, or as microcalcifications, the earliest sign of some cancers including ductal carcinoma in situ. Mammography sees these calcifications beautifully, which is its single biggest advantage. The catch is that both glandular tissue and tumours appear white, so in dense breasts a cancer can be camouflaged.

The radiation dose from a standard four-view mammogram is roughly 0.4 mSv, about the same as seven weeks of ordinary background radiation we all receive from the environment. For women in the screening age range, the benefit of catching cancer early far outweighs this small theoretical risk.

Ultrasound sends high-frequency sound waves from a hand-held transducer into the breast; the echoes that bounce back are turned into a real-time image. There is no radiation. Ultrasound clearly separates solid lumps from simple cysts (which are almost always harmless), describes a lump's shape, edges and blood flow, and lets the radiologist watch the needle during a biopsy.

One important point: ultrasound is operator-dependent. The same machine can give an excellent or a poor scan depending on the skill of the person doing it. This is why a breast ultrasound is best done at a centre with experienced breast radiologists rather than a general scan centre.

MRI (magnetic resonance imaging) is a third option using strong magnets and a contrast injection. It is the most sensitive test of all but flags many harmless findings, so it is reserved for specific situations such as very high-risk screening, not for routine use. We cover it later in this guide.

Screening means looking for cancer in a woman with no symptoms. Different bodies set slightly different ages, but they all agree that mammography is the core screening test.

Internationally, the American Cancer Society suggests women may start annual mammograms at 40 to 44, recommends them at 45 to 54, and offers annual or two-yearly screening from 55. The US Preventive Services Task Force recommends two-yearly mammograms from age 40, and the NCCN recommends annual mammograms from 40.

In India, guidance from bodies such as ICMR, the Indian Association of Surgical Oncology and FOGSI generally points to starting mammographic screening around age 40 to 45 for average-risk women, often combined with a clinical breast examination by a doctor. The reason for an earlier start than the West is striking: Indian breast cancer is typically diagnosed around 47 to 50 years, compared with about 62 in the US, and a larger share of cases occur before menopause. Our deeper guide to breast cancer detection and treatment in India explains why this matters.

A few practical points on screening:

Breast density describes how much glandular and fibrous tissue you have compared with fat. The radiologist grades it from A (almost entirely fatty) to D (extremely dense). Categories C and D count as "dense breasts." You cannot tell your density from how your breasts feel; only a mammogram shows it.

Density matters for two reasons. First, dense tissue is itself a modest, independent risk factor for breast cancer. Second, and more practically, dense tissue is white on a mammogram, and so is cancer, so tumours are easier to miss. In fatty breasts a mammogram catches roughly 85 to 90 percent of cancers; in very dense breasts that can fall to 50 to 70 percent.

This is not a minor footnote for Indian women. South Asian women tend to have denser breasts, and studies in Indian populations report that a large proportion, often cited as 40 to 60 percent or more, especially among younger women, fall into category C or D.

What to do if you have dense breasts:

Diagnostic imaging is different from screening: it is done to work out a specific symptom or a finding from a screening mammogram. The test chosen depends on the problem and your age. Most breast lumps are benign, but every persistent new lump deserves a proper look rather than a wait-and-watch at home.

A palpable lump. In a woman under 30, ultrasound is usually the first test, because young breasts are dense and we prefer to avoid radiation; mammography is added only if needed. In a woman 30 or older, both mammogram and ultrasound are typically done. Ultrasound is what tells a harmless cyst apart from a solid lump such as a Fibroadenoma of the Breast in India: Symptoms, Diagnosis & Cost, the most common solid breast lump in younger women.

Nipple discharge. Discharge that is spontaneous, from one breast, from a single duct, bloody, or persistent is the kind that needs evaluation, usually with both mammogram and ultrasound, sometimes with a special duct study (ductography). Milky discharge from both breasts is a different situation. Our guide to the causes of nipple discharge explains which types are reassuring and which are not.

Skin changes. Skin thickening, an orange-peel texture, dimpling, nipple pulling inward, or eczema-like changes of the nipple all deserve prompt mammogram-plus-ultrasound evaluation. These can be signs of less common but serious conditions such as inflammatory breast cancer or Paget's disease.

Breast pain alone. Pain by itself, particularly when it is in both breasts and linked to your cycle, rarely signals cancer and often needs no imaging. Our explainer on cyclical breast pain and on breast tenderness across the menstrual cycle can help you tell ordinary hormonal pain from something that needs review. Focal, one-sided pain that will not settle may warrant a scan.

Swollen armpit nodes are assessed with ultrasound of the armpit alongside breast imaging, with a needle sample if anything looks suspicious.

Pregnancy and breastfeeding change the breast a lot, and those changes can produce lumps, density, and discharge that may be perfectly normal or, rarely, not. Because we avoid unnecessary radiation in pregnancy, ultrasound is the primary test here. It can assess a lump, separate a cyst from a solid mass, and guide a biopsy if one is needed, all without radiation.

Mammography can still be done in pregnancy when truly needed, with a lead shield over the abdomen, and the dose to the baby is very low. But it is reserved for when ultrasound is not enough or suspicion of cancer is high.

During breastfeeding the breast is glandular and dense, which makes mammograms harder to read and ultrasound more useful. Common breastfeeding issues that may need a scan include a galactocele (a milk-filled cyst, easily seen on ultrasound), a blocked duct, or a suspected abscess. If you are dealing with painful, red, swollen breast tissue, our guide to mastitis and blocked ducts while breastfeeding covers when an ultrasound is needed. A diagnostic ultrasound can be done without stopping breastfeeding, and you can read more about normal breast changes in pregnancy and postpartum.

The key safety message: a lump, skin change, or bloody nipple discharge during pregnancy or breastfeeding should be evaluated, not brushed off as "just hormones." Pregnancy-associated breast cancer is uncommon, but pregnancy changes can mask it and delay diagnosis, so any persistent or unusual finding deserves a careful look and, if needed, a core biopsy.

Indian radiologists report breast scans using BIRADS (Breast Imaging Reporting and Data System), a standard scale from 0 to 6. Knowing what your category means tells you what happens next, and usually calms a lot of unnecessary worry.

Mammogram and ultrasound handle the vast majority of breast imaging, but a few other tools have specific roles.

Breast MRI is the most sensitive test for cancer (often 90 to 95 percent), but it flags many benign findings too, and it is expensive (around Rs 8,000 to 25,000 in India). It is used for high-risk screening (BRCA carriers, very strong family history, childhood chest radiation), for sorting out findings that mammogram and ultrasound cannot settle, and for mapping the extent of a newly diagnosed cancer. It is done lying face-down with a contrast injection and takes 30 to 45 minutes. Big centres such as AIIMS, Tata Memorial, Apollo and Fortis offer it.

Tomosynthesis (3D mammography) is increasingly the default for screening and diagnosis, especially in dense breasts, because it detects more cancers and triggers fewer false alarms than flat 2D mammography.

Automated breast ultrasound (ABUS) scans the whole breast in a standardised way and is used at some centres for supplemental screening in dense breasts.

Contrast-enhanced spectral mammography (CESM) combines a mammogram with a contrast injection and can play an MRI-like role in some situations; it is becoming more available in major Indian cities.

PET-CT and nuclear medicine scans are for staging a known cancer and checking response to treatment, not for routine screening or first diagnosis.

Access varies a lot across India. Metros have academic centres, large private hospitals, dedicated breast clinics and chain labs, while smaller towns may mean travelling for specialised imaging like MRI or tomosynthesis. Government and teaching hospitals offer these services far more cheaply, and sometimes free, than private centres. The Ayushman Bharat scheme covers breast imaging for eligible beneficiaries at empanelled hospitals.

Typical private-centre costs (Apollo, Fortis, SRL, Metropolis and similar):

Use this as a starting map, not a substitute for your doctor's judgement. The right test for your exact situation depends on your full history.

Breast cancer is the most common cancer in Indian women, with roughly 200,000 new cases a year and a rising trend, especially in cities. While the rate per 100,000 women is lower than in the West, the absolute numbers are huge given India's population.

Indian breast cancer also behaves differently. It is diagnosed younger (median around 47 to 50 years), a larger share occurs before menopause, and too many women present at an advanced stage, partly because of delay and limited screening. That is precisely why earlier screening ages and quick evaluation of any change are emphasised here.

Real barriers get in the way: reluctance to discuss breast issues, discomfort with examination, fear of a cancer diagnosis, low awareness, cost, and patchy rural access. Where it helps, women can ask for a female radiologist or clinician. Family history matters a lot, a mother, sister or daughter with breast cancer, especially young or in both breasts, is a reason to consider earlier and more intensive screening and possibly genetic testing.

The encouraging part: treatment in India is widely available and improving, at centres such as Tata Memorial, AIIMS, the Cancer Institute in Chennai, and major private cancer departments. Outcomes for early-stage cancer are excellent. The single biggest lever we have is catching cancer earlier, through sensible screening and by never ignoring a new symptom.

Book an appointment, rather than waiting for your next routine scan, if you notice any of the warning signs below. Early evaluation is reassuring far more often than not, and when something is found, finding it early changes everything.

• World Health Organization — Breast cancer
• American Cancer Society — Breast Cancer Screening Guidelines
• U.S. Preventive Services Task Force — Breast Cancer: Screening (2024)
• American College of Radiology — BI-RADS Atlas
• ICMR — Consensus Document for Management of Breast Cancer
• National Cancer Institute — Mammograms